Lincoln National Corporation

▲ Bull Case

• ◆4x adj. EPS on 12%+ adj. operating ROE is a fundamental mispricing: any insurer generating ROE 200-300bps above its cost of capital (WACC ~9-10%) should not trade at 4x earnings; 8 consecutive clean quarters increasingly confirms the earnings are real and reserve adequacy is restored.
• ◆Product mix shift to FIA/RILA is a structural ROIC improvement: FIA/RILA require 15-25% less statutory capital per dollar of premium than legacy VAs; as mix shifts from ~55% to ~70-75% FIA/RILA over 3-4 years, adj. operating ROE improves from 12-13% toward 16-17% through pure capital efficiency compounding.
• ◆AFS unrealized losses are a free call option on rate normalization: $7.9B AFS unrealized loss is not an economic loss on a hold-to-maturity portfolio; as rates normalize (Fed already cut 100bps), these losses reverse and recover $30-40/share in GAAP book value, removing a recurring source of analyst skepticism and enabling multiple re-rating from 4x to 8-10x adj. EPS.

▼ Bear Case

• ◆Reserve adequacy is unverifiable for outsiders over a 20-30 year liability tail: 8 quarters of data cannot confirm whether a 30-year assumption is correct; the market is rationally maintaining a discount that can only be resolved by time, and any new reserve charge — even a modest one — would reset the clock on investor confidence.
• ◆AFS losses could become real if forced liquidation occurs: if a claims spike or capital event forces Lincoln to sell bonds before maturity, the $7.9B mark-to-market loss becomes economic; while the 420% RBC buffer reduces this probability, it is a non-zero tail scenario that is difficult to fully dismiss.
• ◆Competitive and governance risks compound the uncertainty: the combined Chair/CEO structure (46% AGM dissent) creates unresolved governance overhang; Group Protection faces direct competition from Unum and MetLife at scale; and management continuity risk exists if Ellen Cooper departs before the thesis is fully validated.

“The central debate is whether Lincoln's reserves are truly adequate or whether the 2022 charge was the first of several. Bulls point to 8 consecutive clean quarters, the Bain Capital captive reinsurance partnership quarantining the legacy VA book, Cooper's actuarial re-run, and the July 2025 dismissal of the securities fraud class action as converging evidence that further charges are unlikely (<10% probability). Bears counter that life insurance reserve models span 20-30 year liability tails, making it impossible for outside investors to verify adequacy with only 8 quarters of data — the risk is structurally unresolvable in the near term, justifying a permanent discount. The secondary debate concerns AFS losses: bulls view them as non-economic on a hold-to-maturity portfolio that will reverse as rates normalize; bears note the tail scenario where forced liquidation makes the losses real, though this requires capital inadequacy that the 420% RBC ratio currently contradicts. Resolution requires continued clean quarters and time.”

• ◆Q2-Q3 2026 clean earnings (9th-10th consecutive quarter) further compresses reserve fear premium and drives analyst upgrades
• ◆FY2026 annual actuarial review (Q4 2026/Q1 2027) returning clean results triggers institutional re-entry
• ◆AFS unrealized losses declining below $5B improves GAAP narrative and removes a recurring source of skepticism
• ◆Chair/CEO separation announced, removing governance overhang and signaling confidence in operational stability
• ◆Large buyback authorization at $35 price signals management confidence and is highly accretive at 4x P/E
• ◆FY2026 adj. EPS ≥$9.25 achieved or exceeded, driving consensus target price upgrades

• ◆Reserve charge >$500M in any quarter — probability ~20%; charge >$1B is a kill switch triggering full exit
• ◆Adj. operating ROE declining below 10% for two consecutive quarters, indicating business deterioration beyond mix-shift offset
• ◆Rate spike (+200bps) worsening AFS unrealized losses and creating narrative deterioration even without economic impairment
• ◆RBC ratio falling below 380%, triggering regulatory scrutiny and potential dividend cut or dilutive equity raise
• ◆FIA/RILA mix shift stalling or reversing, breaking the capital efficiency improvement thesis
• ◆CEO Ellen Cooper departing without a clear succession plan during the critical thesis validation period